Care.com Inc.Find Ratings Reports
CARE.COM INC's gross profit margin for the second quarter of its fiscal year 2019 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. CARE.COM INC is extremely liquid. Currently, the Quick Ratio is 2.72 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
During the same period, stockholders' equity ("net worth") has increased by 5.40% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY19||Q2 FY18|
|Net Sales ($mil)||50.98||45.97|
|Net Income ($mil)||-64.81||-0.17|
|Balance Sheet||Q2 FY19||Q2 FY18|
|Cash & Equiv. ($mil)||125.15||113.55|
|Total Assets ($mil)||240.51||203.16|
|Total Debt ($mil)||26.78||0.0|
|Profitability||Q2 FY19||Q2 FY18|
|Gross Profit Margin||73.82||78.74|
|Return on Assets||-6.43||5.26|
|Return on Equity||-15.46||4.44|
|Debt||Q2 FY19||Q2 FY18|
|Share Data||Q2 FY19||Q2 FY18|
|Shares outstanding (mil)||32.74||31.24|
|Div / share||0.0||0.0|
|Book value / share||4.96||4.93|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||651961.0||567900.0|
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. To use another comparison, its price-to-book ratio of 2.22 indicates a discount versus the S&P 500 average of 3.31 and a significant discount versus the subsector average of 5.05. The price-to-sales ratio is below the S&P 500 average and is well below the subsector average, indicating a discount. After reviewing these and other key valuation criteria, CARE.COM INC proves to trade at a discount to investment alternatives.
|CRCM NM||Peers 26.78||CRCM 16.25||Peers 17.94|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
CRCM's P/E is negative making this valuation measure meaningless.
Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
CRCM is trading at a valuation on par to its peers.
|CRCM 21.13||Peers 16.89||CRCM NA||Peers 0.24|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
CRCM is trading at a significant premium to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|CRCM 2.22||Peers 5.05||CRCM -500.00||Peers 69.13|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CRCM is trading at a significant discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, CRCM is expected to significantly trail its peers on the basis of its earnings growth rate.
|CRCM 1.77||Peers 6.47||CRCM 11.66||Peers 21.72|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CRCM is trading at a significant discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
CRCM significantly trails its peers on the basis of sales growth.